Pneumocystis jirovecii pneumonia: Difference between revisions

No edit summary
Line 16: Line 16:


== Differential Diagnosis==
== Differential Diagnosis==
*[[Dyspnea (SOB)]]
{{SOB DDX}}


== Diagnosis ==
== Diagnosis ==

Revision as of 10:28, 1 August 2015

Background

  • Pneumocystis (carinii) jiroveci
  • Most common opportunistic infection in AIDS pts
  • Most common identifiable cause of death
  • Risk factors:
    • CD4 < 200
    • Immunosuppressive medications
    • Cancer
    • Primary immunodeficiencies
    • Severe malnutrition

Clinical Features

  • Fever (62%)
  • Dry cough
  • Shortness of breath (progressive from exertion only to at rest)

Differential Diagnosis

Acute dyspnea

Emergent

Non-Emergent

Diagnosis

Work-Up

  • CBC
  • Chemistry
  • LDH
  • ABG
  • CD4 count
  • CXR - bat wing appearance (bilat interstitial infiltrates)
  • A-a gradient
    • P(A-a)O2 = 145 – PaCO2 – PaO2 (normal is <10 in young, healthy pts)

Evaluation

  • Imaging
    • CXR
      • Normal in 25% of cases
      • Diffuse, interstitial infiltrates
    • CT Chest
      • Sn 100%, Sp 89%
      • May see ground glass infiltrative pattern
  • Labs
    • LDH
      • Low Sn, Sp
    • ABG
      • Hypoxemia, increased A-a gradient

Treatment

Antibiotics

Mild Disease

  • TMP/SMX 2 DS tablets PO q8hrs daily OR
    • High incidence of allergy in HIV
  • Dapsone 100mg PO once daily + TMP 5mg/kg PO q8hrs OR
    • caution: dapsone can cause methemoglobinemia
  • Atavaquone 750mg PO q12hrs OR
  • Primaquine 30mg PO q24hrs + Clindamycin 450mg PO q8hrs

Severe Disease

  • TMP/SMX 5mg/kg IV q8hrs daily x 21 days OR
  • Pentamidine 4mg/kg IV daily infused over 60 minutes OR
    • Watch for side effects of hypoglycemia and hypotension
  • Primaquine 30mg PO once daily + Clindamycin 900mg IV q8hrs daily

Prophylaxis

  • TMP/SMX 1 double strength tablet daily, but one single strength tablet daily or one double-strength three times weekly is acceptable.[1]

Disposition

  • Symptoms usually worsen 2-3d after start of treatment
  • Patients with disease severe enough to warrant IV therapy or steroids should be admitted

References

  1. CDC Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus http://www.cdc.gov/mmwr/preview/mmwrhtml/00001957.htm